Assessment of Arterial Stiffness in Female and Male Gout Patients

REFERENCES

• Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007; 116:894–900.
   PubMed Web of Science ®Google Scholar
• Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007; 115:2526–2532.
   PubMed Web of Science ®Google Scholar
• Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006; 47:51–59.
   PubMed Web of Science ®Google Scholar
• Niskanen LK, Laaksonen DE, Nyyssonen K. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004; 164:1546–1551.
   PubMed Web of Science ®Google Scholar
• Nelson MR, Stepanek J, Cevette M, Covalciuc M, Hurst RT, Tajik AJ. Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform? Mayo Clin Proc 2010; 85(5):460–472.
   PubMed Web of Science ®Google Scholar
• Asmar R, Benetos A, Topouchian J. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26:485–490.
   PubMed Web of Science ®Google Scholar
• Laurent S, Cockcroft J, Van Bortel L. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588–2605.
   PubMed Web of Science ®Google Scholar
• Mattace-Raso FU, van der Cammen TJ, Hofman A. Arterial stiffness and risk of coronary heart diseaseand stroke: the Rotterdam Study. Circulation 2006; 113:657–663.
   PubMed Web of Science ®Google Scholar
• Brook RD, Yalavarthi S, Myles JD. Determinants of vascular function in patients with chronic gout. J Clin Hypertension 2011; 13(3):178–188.
   Web of Science ®Google Scholar
• Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20(3):895–900.
   PubMed Web of Science ®Google Scholar
• Wei W, Tölle M, Zidek W, Van der Giet M. Validation of the mobil-O-Graph: 24 h-blood pressure measurement device. Blood Press Monit 2010; 15(4):225–228.
   PubMed Web of Science ®Google Scholar
• Wassertheurer S, Kropf J, Weber T. A new oscillometric method for pulse wave analysis: comparison with a common tonometric method. J Hum Hypertens 2010; 24(8):498–504.
   PubMed Web of Science ®Google Scholar
• Timio M, Venanzi S, Lolli S. Non-dipper hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995; 43(6):382–387.
   PubMed Web of Science ®Google Scholar
• Choi H, Atkinson K, Karlson E, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men. Arch Intern Med 2005; 165:742–748.
   PubMed Web of Science ®Google Scholar
• Wallace K, Riedel A, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004; 31:1582–1587.
   PubMed Web of Science ®Google Scholar
• Meyers OL, Monteagudo FS. A comparison of gout in men and women: a 10-year experience. S Afr Med J 1986; 70:721–723.
   PubMed Web of Science ®Google Scholar
• Puig JG, Michan AD, Jimenez ML. Female gout: clinical spectrum and uric acid metabolism. Arch Intern Med 1991; 151:726–732.
   PubMed Web of Science ®Google Scholar
• Bhole V, Vera M, Rahman MM, Krishnan E, Choi H. Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum 2010; 62(4):1069–1076.
   PubMed Web of Science ®Google Scholar
• Chirinos JA, Zambrano JP, Chakko S. Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease. Am J Cardiol 2005; 96(5):645–648.
   PubMed Web of Science ®Google Scholar
• Roman MJ, Devereux RB, Kizer JR. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007; 50(1):197–203.
   PubMed Web of Science ®Google Scholar
• Wallace SM, Yasmin, McEniery CM. Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 2007; 50(1):228–233.
   PubMed Web of Science ®Google Scholar
• Weber T, Auer J, O’Rourke MF. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109(2):184–189.
   PubMed Web of Science ®Google Scholar
• London GM, Marchais SJ, Guerrin AP. Arterial stiffness and function in end-stage renal stage. Adv Chronic Kidney Dis 2004; 11(2):202–209.
   PubMed Web of Science ®Google Scholar
• Brooks BA, Molyneaux LM, Yue DK. Augmentation of central arterial pressure in Type 2 diabetes. Diabet Med 2001; 18(5):374–380.
   PubMed Web of Science ®Google Scholar
• Wilkinson IB, Prasad K, Hall IR. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol 2002; 39(6):1005–1011.
   PubMed Web of Science ®Google Scholar
• Kullo IJ, Seward JB, Bailey KR. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens 2005; 18(8):1123–1129.
   PubMed Web of Science ®Google Scholar
• Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005; 118(8):816–826.
   PubMed Web of Science ®Google Scholar
• Agamah ES, Srinivasan SR, Webber LS, Berenson GS. Serum uric acid and its relation to cardiovascular disease risk factors in children and young adults from a biracial community: the Bogalusa Heart Study. J Lab Clin Med 1991; 18:241–249.
   Google Scholar
• Alderman MH. Podagra, uric acid, and cardiovascular disease. Circulation 2007; 116(8):880–883.
   PubMed Web of Science ®Google Scholar
• Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16(12):3553–3562.
   PubMed Web of Science ®Google Scholar
• Ward H. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998; 352:670–671.
   PubMed Web of Science ®Google Scholar
• Liese AD, Hense HW, Lowel H, Doring A, Tietze M, Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization monitoring trends and determinants in cardiovascular diseases. Epidemiology 1999; 10:391–397.
   PubMed Web of Science ®Google Scholar
• Bengtsson C, Lapidus L, Stendahl C, Waldenstrom J. Hyperuricemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scan 1988; 224:549–555.
   PubMed Web of Science ®Google Scholar
• The Coronary Drug Project Research Group. Serum uric acid: its association with other risk factors and with mortality in coronary heart disease. J Chron Dis 1976; 29:557–569.
   PubMedGoogle Scholar
• Reunanen A, Takkunen H, Knekt P, Aromaa A. Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl 1982; 668:49–59.
   PubMedGoogle Scholar
• Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131:7–13.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Kang DH, Feig D. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41:1183–1190.
   PubMed Web of Science ®Google Scholar
• Khosla UM, Zharikov S, Finch JL. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67:1739–1742.
   PubMed Web of Science ®Google Scholar
• Perlstein TS, Gumieniak O, Hopkins PN. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int 2004; 66:1465–1470.
   PubMed Web of Science ®Google Scholar
• Jossa F, Farinaro E, Panico S. Serum uric acid and hypertension: the Olivetti Heart Study. J Hum Hypertens 1994; 8:677–681.
   PubMed Web of Science ®Google Scholar
• Zhang W, Sun K, Yang Y, Hu F, Hui R. Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis. Clin Chem 2009; 55:2026–2034.
   PubMed Web of Science ®Google Scholar
• White W. Diurnal blood pressure and blood pressure variability in diabetic normotensive and hypertensive subjects. J Hypertens 1992; 10(Suppl. 1):S35–S41.
   Google Scholar
• Timio M, Venanzi S, Lolli G. Non-dipper hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995; 43:382–383.
   PubMed Web of Science ®Google Scholar
• Parati G. Blood pressure reduction at night: sleep and beyond. J Hypertens 2000; 18:1725–1729.
   PubMed Web of Science ®Google Scholar